HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
oxendolone
Also Known As:
16 beta-ethyl-17 beta-hydroxyestr-4-en-3-one; 16 beta-ethyl-19-nortestosterone; 16 ethyl-17-hydroxy-4-estren-3-one; EHOO; TSAA 291; TSAA-291; TSAA291; (16 beta,17 beta)-16-ethyl-17-hydroxyestr-4-en-3-one
Networked:
10
relevant articles (
0
outcomes,
3
trials/studies)
Bio-Agent Context: Research Results
Polycyclic Compounds: 6
Fused-Ring Compounds
Steroids: 70059
Estranes
Estrenes
Nandrolone: 245
oxendolone: 10
Hormones, Hormone Substitutes, and Hormone Antagonists
Hormones: 80400
Gonadal Hormones: 716
Gonadal Steroid Hormones: 7657
Testosterone Congeners: 112
Nandrolone: 245
oxendolone: 10
Related Diseases
1.
Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
04/01/1984 - "
These findings suggest that oxendolone is the drug of choice for non-surgical treatment of benign prostatic hyperplasia.
"
04/01/1984 - "
[Clinical experience with oxendolone for treatment of benign prostatic hyperplasia.
"
01/01/1989 - "
In a randomized triple-blind multicentre study, injections with the anti-androgenic agent oxendolone were compared with placebo in the treatment of benign prostatic hyperplasia.
"
01/01/1988 - "
Study of the effect of an anti-androgen (oxendolone) on experimentally induced canine prostatic hyperplasia.
"
01/01/1988 - "
Study of the effect of an anti-androgen (oxendolone) on experimentally induced canine prostatic hyperplasia.
"
2.
Body Weight (Weight, Body)
06/01/1984 - "
After successive treatments of male rats with TSAA-291 in an aqueous suspension in daily doses of 5, 15 and 50 mg/kg body weight for two weeks, serum TSAA-291 levels were determined by the radio immunoassay and calculated to be 22.7, 76.9 and 194.9 ng/ml, respectively.
"
01/01/1979 - "
Intramuscular administration of a new steroidal anti-androgen, TSAA-291 (16 beta-ethyl-17 beta-hydroxy-4-oestren-3-one), in doses of 0.05, 0.5 and 5 mg/kg body weight reduced the in vivo uptake of [3H]testosterone by the ventral prostate of castrated rats of 78, 59 and 37% of the control level, respectively.
"
3.
Prostatism
11/01/1987 - "
[Clinical efficacy of oxendolene (antiandrogen) and bunazosin hydrochloride (alpha-adrenergic blocker) in the treatment of prostatism--comparative study of oxendolone, bunazocin hydrochloride and their combination].
"
4.
Neoplasms (Cancer)
11/30/1990 - "
At a 2 mg daily dose for 13 days, (1) and AA560 powerfully inhibited tumor growth in castrated DS mice treated with testosterone propionate but oxendolone had almost no effect.
"
5.
Granuloma
01/01/1979 - "
(5) Anti-inflammatory activity : Daily subcutaneous dose of 20 mg of TSAA-291 for 6 days did not significantly depress the weight of granuloma developed around the cotton-pellet implanted in the young male rat.
"
Related Drugs and Biologics
1.
Androgens
2.
Androgen Antagonists (Antiandrogens)
3.
Testosterone Propionate
4.
Adrenergic Antagonists (Antiadrenergic Agents)
5.
Testosterone (Sustanon)
6.
Suspensions
7.
Steroids
8.
Androgen Receptors (Androgen Receptor)
9.
Chlormadinone Acetate (Chlormadinone)
10.
Allylestrenol
Related Therapies and Procedures
1.
Injections
2.
Conservative Treatment